HE
Hedyeh Ebrahimi
City Of Hope National Medical Center, Tehran University of Medical Sciences
Research areas: Medicine · Oncology · Renal cell carcinoma treatment · Cancer Immunotherapy and Biomarkers · Prostate Cancer Treatment and Research
0000-0003-3647-7356
Employment
-
City Of Hope National Medical Center Postdoctoral Fellow
Education
Projects & Funding
Projects & funding information is unavailable.
Publications (63)
- Data from Comprehensive Profiling of Cell Surface Proteins in Testicular Germ Cell Tumors Save
- Figure 1 from Comprehensive Profiling of Cell Surface Proteins in Testicular Germ Cell Tumors Save
- Supplementary Table 1 from Comprehensive Profiling of Cell Surface Proteins in Testicular Germ Cell Tumors Save
- Supplementary Table 2 from Comprehensive Profiling of Cell Surface Proteins in Testicular Germ Cell Tumors Save
- Table 1 from Comprehensive Profiling of Cell Surface Proteins in Testicular Germ Cell Tumors Save
- Comprehensive Profiling of Cell Surface Proteins in Testicular Germ Cell Tumors Save
- Data from Unique Spectrum of Activating BRAF Alterations in Prostate Cancer Save
- Supplementary Data 1 from Unique Spectrum of Activating BRAF Alterations in Prostate Cancer Save
- Supplementary Figure 1 from Unique Spectrum of Activating BRAF Alterations in Prostate Cancer Save
- Supplementary table 1 from Unique Spectrum of Activating BRAF Alterations in Prostate Cancer Save
- Supplementary table 2 from Unique Spectrum of Activating BRAF Alterations in Prostate Cancer Save
- Clinical Predictors and Prognostic Significance of Pathologic Disease Upstaging at Radical Cystectomy in Patients with Muscle-Invasive Bladder Cancer Save
- BRCA To the Future: Platinum Chemotherapy in Biomarker-Selected Metastatic Castrate Resistant Prostate Cancer Save
- Comparative Genomic Characterization of Small Cell Carcinoma of the Bladder Compared With Urothelial Carcinoma and Small Cell Lung Carcinoma Save
- Cabozantinib and nivolumab with or without live bacterial supplementation in metastatic renal cell carcinoma: a randomized phase 1 trial Save
- First-line Systemic Therapy Following Adjuvant Immunotherapy in Renal Cell Carcinoma: An International Multicenter Study. Save
- Prevalence of Dietary Modification and Supplement Use in Patients with Metastatic Renal Cell Carcinoma Receiving Systemic Therapy. Save
- Impact of Synchronous versus Metachronous Metastasis on Outcomes in Patients with Metastatic Renal Cell Carcinoma Treated with First-line Immune Checkpoint Inhibitor-based Combinations. Save
- Barriers to Clinical Trial Implementation Among Community Care Centers. Save
- Burden of Ischemic Heart Disease and Its Attributable Risk Factors in North Africa and the Middle East, 1990 to 2019: Results From the GBD Study 2019 Save